Clinical Trial Update: Novel Hemostatic Cardiac Risk Factors in Framingham

View source ↗

Summary

An NHLBI-sponsored Framingham clinical trial investigated novel hemostatic factors as cardiac risk factors; the study has completed, examining associations with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Cardiovascular Diseases
• Carotid Artery Disease
• Heart Disease
• Myocardial Infarction
• Sudden Cardiac Death
• Thrombosis

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Cardiovascular Diseases, Heart Diseases | Status: COMPLETED